Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

Figure 3

A schematic summary of the therapeutics that have been identified in the inflammatory pathway. The inflammatory state occurs as a result of hyperglycemia and is seen in patients with both type 1 and 2 diabetes.